|
|
|
Insider
Information: |
Doyle Anthony |
Relationship: |
Chief Financial Officer |
City: |
Durham |
State: |
NC |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
266,744 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,717,831 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
266,744 |
|
|
Total
Value |
$1,717,831 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biocryst Pharmaceuticals Inc |
BCRX |
Chief Financial Officer |
2024-05-14 |
266,744 |
2020-08-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BCRX |
Biocryst Pharmaceuticals ... |
Chief Financial Officer |
|
2021-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
115,000 |
208,719 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Chief Financial Officer |
|
2021-12-14 |
4/A |
A |
$0.00 |
$0 |
D/D |
75,000 |
168,719 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Chief Financial Officer |
|
2022-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
34,000 |
197,966 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Chief Financial Officer |
|
2023-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
34,000 |
235,401 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Chief Financial Officer |
|
2023-12-19 |
4 |
D |
$6.05 |
$15,016 |
D/D |
(2,482) |
227,444 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Chief Financial Officer |
|
2023-12-14 |
4 |
D |
$6.43 |
$35,204 |
D/D |
(5,475) |
229,926 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Chief Financial Officer |
|
2022-12-15 |
4 |
AS |
$10.90 |
$62,130 |
D/D |
(5,700) |
163,966 |
0 |
% |
|
BCRX |
Biocryst Pharmaceuticals ... |
Chief Financial Officer |
|
2024-05-14 |
4 |
B |
$5.57 |
$202,191 |
D/D |
36,300 |
266,744 |
2.74 |
% |
|
BCRX |
Biocryst Pharmaceuticals ... |
Chief Financial Officer |
|
2020-08-11 |
4 |
B |
$4.08 |
$220,320 |
D/D |
54,000 |
54,000 |
2.74 |
% |
|
9 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|